You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DCR-PHXC

Showing 1 - 25 of 183
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Hyperoxaluria Type 3 Trial in Worldwide (DCR-PHXC, Sterile Normal Saline (0.9% NaCl))

Completed
  • Primary Hyperoxaluria Type 3
  • DCR-PHXC
  • Sterile Normal Saline (0.9% NaCl)
  • Boston, Massachusetts
  • +5 more
Sep 9, 2021

Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)

Enrolling by invitation
  • Primary Hyperoxaluria Type 1 (PH1)
  • +5 more
  • DCR-PHXC
  • San Francisco, California
  • +19 more
Jun 22, 2022

Primary Hyperoxaluria, Primary Hyperoxaluria Type 2, End Stage Renal Disease Trial in Spain, United Kingdom, United States

Recruiting
  • Primary Hyperoxaluria
  • +2 more
  • DCR-PHXC
  • Rochester, Minnesota
  • +4 more
Jul 7, 2021

Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2 Trial in Worldwide (nedosiran)

Not yet recruiting
  • Primary Hyperoxaluria
  • +2 more
  • (no location specified)
Sep 8, 2021

Primary Hyperoxaluria Trial in Worldwide (DCR-PHXC, Placebo)

Completed
  • Primary Hyperoxaluria
  • DCR-PHXC
  • Placebo
  • Boston, Massachusetts
  • +6 more
Jan 17, 2020

Primary Hyperoxaluria Type 1 (PH1) Trial (Nedosiran)

Available
  • Primary Hyperoxaluria Type 1 (PH1)
  • (no location specified)
Aug 7, 2023

Primary Hyperoxaluria Type 3 Trial in Worldwide

Recruiting
  • Primary Hyperoxaluria Type 3
    • Boston, Massachusetts
    • +12 more
    Nov 16, 2021

    Dynamic Chest X-ray With Simultaneous Spirometry

    Not yet recruiting
    • Cystic Fibrosis
    • Dynamic chest x-ray
    • Spirometry
    • (no location specified)
    Nov 2, 2023

    Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)

    Active, not recruiting
    • Alcohol Use Disorder
    • Glendale, California
      Parexel Los Angeles Early Phase Clinical Unit
    Apr 26, 2023

    Solid Tumor, Adult, Refractory Tumor Trial in Dallas, San Antonio (DCR-STAT3)

    Recruiting
    • Solid Tumor, Adult
    • Refractory Tumor
    • Dallas, Texas
    • +1 more
    Oct 21, 2023

    Alcohol Use Disorder (AUD) Trial in Glendale (DCR-AUD, Placebo for DCR-AUD)

    Active, not recruiting
    • Alcohol Use Disorder (AUD)
    • Glendale, California
      Parexel Los Angeles Early Phase Clinical Unit
    Sep 15, 2022

    Hepatitis B, Chronic Trial in Worldwide (DCR-HBVS, Placebo for DCR-HBVS)

    Completed
    • Hepatitis B, Chronic
    • Clayton, Victoria, Australia
    • +8 more
    Sep 28, 2022

    Colorectal Cancer Trial in Shanghai (Fruquintinib+mFOLFOX6/FOLFIRI)

    Recruiting
    • Colorectal Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 23, 2023

    Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

    Recruiting
    • Untreated Advanced Non-small Cell Lung Cancer
    • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital
    Nov 13, 2023

    Colorectal Cancer Trial in Shanghai (FOLFIRI+Bevacizumab)

    Recruiting
    • Colorectal Cancer
    • Shanghai, Pudong, China
      Affiliated Cancer Hospital of Fudan University
    Jul 24, 2023

    Biliary Tract Cancer Trial in Kaohsiung, Taichung (D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX)

    Recruiting
    • Biliary Tract Cancer
    • D07001-softgel capsules + Xeloda (or TS-1)
    • mFOLFOX
    • Kaohsiung, Taiwan
    • +4 more
    Dec 22, 2022

    Hepatocellular Carcinoma, Lenvatinib, Tislelizumab Trial in Hangzhou (TACE, Tislelizumab, Lenvatinib)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +5 more
    • TACE
    • Tislelizumab, Lenvatinib
    • Hangzhou, Zhejiang, China
      1# Banshan East Rd. Zhejiang cancer hospital
    Jun 17, 2023

    Hematological Malignancies Trial in Worldwide (Pembrolizumab/vibostolimab coformuation)

    Recruiting
    • Hematological Malignancies
    • Pembrolizumab/vibostolimab coformuation
    • Duarte, California
    • +64 more
    Jan 27, 2023

    Non Small Cell Lung Cancer, Brain Metastases Trial (Cadonilimab)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Brain Metastases
    • (no location specified)
    Apr 2, 2023

    Alpha 1-Antitrypsin Deficiency Trial in Grafton (Belcesiran)

    Withdrawn
    • Alpha 1-Antitrypsin Deficiency
    • Grafton, Auckland, New Zealand
      Auckland Clinical Studies
    Jun 22, 2022

    Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

    Not yet recruiting
    • Metastatic Gastric Adenocarcinoma
    • +2 more
    • nal-IRI /Experimental
    • +2 more
    • (no location specified)
    Jun 25, 2023

    Hepatocellular Carcinoma Trial (Hepatectomy Combined With Camrelizumab and Apatinib)

    Recruiting
    • Hepatocellular Carcinoma
    • Hepatectomy Combined With Camrelizumab and Apatinib
    • Nanning, China
      Guangxi Medical University Cancer Hospital
    Sep 4, 2022

    Dacryocystorhinostomy, Sedation, General Anesthesia Trial in Bursa (Controlled sedoanalgesia)

    Completed
    • Dacryocystorhinostomy
    • +2 more
    • Controlled sedoanalgesia
    • Bursa, Ni̇lüfer, Turkey
      Bursa Uludağ Üniversitesi Tip Fakültesi
    May 25, 2022

    Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

    Recruiting
    • Advanced Solid Tumor
    • Personalized neoantigen tumor vaccine
    • Shanghai, Shanghai, China
      Ruijin Hospital Shanghai Jiaotong University School of Medicine
    Jun 24, 2023

    Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

    Recruiting
    • Advanced Pancreatic Cancer
    • Personalized neoantigen tumor vaccine
    • Qionghai, Hainan, China
      Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
    Jun 14, 2023